As of Mar 27
| -0.13 / -7.43%|
The 1 analysts offering 12-month price forecasts for MabVax Therapeutics Holdings Inc have a median target of 480.00, with a high estimate of 480.00 and a low estimate of 480.00. The median estimate represents a +29,529.63% increase from the last price of 1.62.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.